• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
FREQUENCY AND CORRELATES OF HYPOGONADISM AMONG A COHORT OF NIGERIAN MEN WITH TYPE 2 DIABETES MELLITUS.尼日利亚2型糖尿病男性队列中性腺功能减退的发生率及其相关因素
Ann Ib Postgrad Med. 2025 Mar 31;23(1):112-120.
2
Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study.替尔泊肽对肥胖患者代谢性性腺功能减退和身体成分的短期影响:一项对照性试点研究。
Reprod Biol Endocrinol. 2025 Jul 2;23(1):92. doi: 10.1186/s12958-025-01425-9.
3
Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis.严重肥胖男性和女性中“肥胖相关性腺功能障碍”的流行情况及其在减重手术后的缓解:系统评价和荟萃分析。
Hum Reprod Update. 2017 Jul 1;23(4):390-408. doi: 10.1093/humupd/dmx012.
4
Perception of patient-centred care and its relationship with management outcomes and complications among patients with DM in Malawi.马拉维糖尿病患者对以患者为中心的护理的认知及其与管理结果和并发症的关系。
BMJ Open. 2025 Jul 5;15(7):e090308. doi: 10.1136/bmjopen-2024-090308.
5
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.糖尿病患者控制血糖的牙周疾病治疗
Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD004714. doi: 10.1002/14651858.CD004714.pub3.
8
Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis.枸橼酸氯米芬治疗性腺功能减退男性:一项系统评价和荟萃分析。
Andrology. 2022 Mar;10(3):451-469. doi: 10.1111/andr.13146. Epub 2022 Jan 8.
9
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.
10
Hypogonadism and its associated factors among adult male type 2 diabetes mellitus patients at the university of gondar comprehensive specialized hospital, Northwest Ethiopia 2024: A comparative cross-sectional study.2024年埃塞俄比亚西北部贡德尔大学综合专科医院成年男性2型糖尿病患者的性腺功能减退及其相关因素:一项比较性横断面研究
PLoS One. 2025 Aug 14;20(8):e0329784. doi: 10.1371/journal.pone.0329784. eCollection 2025.

本文引用的文献

1
Diabetes surpasses obesity as a risk factor for low serum testosterone level.作为血清睾酮水平低的一个风险因素,糖尿病超过了肥胖。
Diabetol Metab Syndr. 2024 Jun 28;16(1):143. doi: 10.1186/s13098-024-01373-1.
2
Assessment of hypogonadism and its determinants among adult men with type 2 diabetes mellitus.评估 2 型糖尿病成年男性的性腺功能减退症及其决定因素。
Prim Care Diabetes. 2023 Aug;17(4):348-353. doi: 10.1016/j.pcd.2023.05.005. Epub 2023 May 13.
3
MicroRNA regulation of the proliferation and apoptosis of Leydig cells in diabetes.微小 RNA 对糖尿病莱迪希细胞增殖和凋亡的调节作用。
Mol Med. 2021 Sep 8;27(1):104. doi: 10.1186/s10020-021-00370-8.
4
Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis.睾酮替代疗法对2型糖尿病或代谢综合征患者的代谢影响:一项荟萃分析。
Int J Endocrinol. 2020 Sep 30;2020:4732021. doi: 10.1155/2020/4732021. eCollection 2020.
5
Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.男性 2 型糖尿病与代谢综合征患者的睾酮治疗代谢效应。
Sex Med Rev. 2019 Jul;7(3):476-490. doi: 10.1016/j.sxmr.2018.12.004. Epub 2019 Feb 22.
6
Hypogonadotropic Hypogonadism in Men With Diabesity.男性糖尿病肥胖症与低促性腺激素性性腺功能减退症。
Diabetes Care. 2018 Jul;41(7):1516-1525. doi: 10.2337/dc17-2510.
7
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.《男性性腺功能减退症睾酮治疗:内分泌学会临床实践指南》。
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744. doi: 10.1210/jc.2018-00229.
8
Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.2型糖尿病男性患者的睾酮治疗——一项随机、双盲、安慰剂对照研究。
Dan Med J. 2017 Jul;64(7).
9
A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.重新评估循环中睾酮的结合:生理和临床意义。
Endocr Rev. 2017 Aug 1;38(4):302-324. doi: 10.1210/er.2017-00025.
10
Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus.2型糖尿病男性性腺功能减退的临床病理评估
Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):667-673. doi: 10.4103/2230-8210.190554.

尼日利亚2型糖尿病男性队列中性腺功能减退的发生率及其相关因素

FREQUENCY AND CORRELATES OF HYPOGONADISM AMONG A COHORT OF NIGERIAN MEN WITH TYPE 2 DIABETES MELLITUS.

作者信息

Adeleye J O, Onasanya A S, Sonuga O O, Esan A, Adebiyi A A

机构信息

Department of Medicine, College of Medicine, University of Ibadan/University College Hospital, Ibadan, Oyo State, Nigeria.

Department of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria.

出版信息

Ann Ib Postgrad Med. 2025 Mar 31;23(1):112-120.

PMID:40852669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12337966/
Abstract

BACKGROUND

Low serum testosterone is reported to be common in men with type 2 diabetes mellitus (type 2 DM). However, the Endocrine society has recommended that the diagnosis of male hypogonadism be based on the presence of symptoms of testosterone deficiency in combination with low serum testosterone.

OBJECTIVE

The aim of this study was to determine the frequency and correlates of hypogonadism in a cohort of Nigerian men with type 2 DM.

METHODS

We studied 100 men with type 2 DM and 100 age matched non-diabetic men in a cross-sectional study. The Androgen Deficiency in the Aging Male (ADAM) questionnaire was administered to all study subjects. Anthropometric parameters, total testosterone, sex hormone binding globulin (SHBG), serum Gonadotrophins, glycated haemoglobin and lipid profile were measured. Serum free testosterone was calculated using Vermeulen's equation. Hypogonadism was considered present in men with symptoms of hypogonadism in combination with a low calculated free testosterone (cFT) < 0.255nmol/l. Data was analysed using SPSS 20 package with level of significance set at p value < 0.05.

RESULTS

41% of men with type 2 DM had hypogonadism, compared to 10% of non-diabetic men. Secondary hypogonadism was found in 22% of men with type 2 DM, while primary hypogonadism was present in 19%. Amongst hypogonadal men with type 2 DM, secondary hypogonadism was the underlying cause in 53.7%. Truncal obesity was identified as a significant independent predictor of hypogonadism.

CONCLUSION

Conclusion: This study demonstrated that hypogonadism was a common condition among men with type 2 DM. Truncal obesity emerged as a significant independent predictor of hypogonadism.

摘要

背景

据报道,2型糖尿病(2型DM)男性中血清睾酮水平低很常见。然而,内分泌学会建议男性性腺功能减退的诊断应基于睾酮缺乏症状与低血清睾酮水平同时存在。

目的

本研究的目的是确定一组尼日利亚2型糖尿病男性中性腺功能减退的发生率及其相关因素。

方法

我们进行了一项横断面研究,研究对象为100名2型糖尿病男性和100名年龄匹配的非糖尿病男性。对所有研究对象进行了老年男性雄激素缺乏(ADAM)问卷调查。测量了人体测量参数、总睾酮、性激素结合球蛋白(SHBG)、血清促性腺激素、糖化血红蛋白和血脂谱。使用Vermeulen方程计算血清游离睾酮。性腺功能减退被定义为伴有性腺功能减退症状且计算出的游离睾酮(cFT)<0.255nmol/l的男性。使用SPSS 20软件包进行数据分析,显著性水平设定为p值<0.05。

结果

2型糖尿病男性中有41%存在性腺功能减退,而非糖尿病男性中这一比例为10%。2型糖尿病男性中22%为继发性性腺功能减退,19%为原发性性腺功能减退。在2型糖尿病性腺功能减退男性中,继发性性腺功能减退是53.7%的潜在病因。躯干肥胖被确定为性腺功能减退的一个重要独立预测因素。

结论

本研究表明,性腺功能减退在2型糖尿病男性中是一种常见情况。躯干肥胖是性腺功能减退的一个重要独立预测因素。